paclitaxelThe combination of paclitaxel (Taxol;) and carboplatin was evaluated in a phase I/II trial in previously untreated patients with advanced ovarian cancer. Groups of patients received different doses of paclitaxel administered by 3- or 24-h infusions, as well as different doses of ...
Carboplatin and Paclitaxel (Taxol) versus Carboplatin and Paclitaxel (Taxol) followed by Carboplatin for frontline chemotherapy in advanced ovarian carcinoma. A Hellenic Cooperative Oncology Group Study,Hellenic Cooperative Oncology Group,Interventional,
A phase I trial of carboplatin plus paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) therapy for untreated patients with advanced ovarian cancer has been completed, demonstrating that these drugs can be combined in full doses with acceptable toxicity. This combination has now gone fo...
Paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) appears to be one of the most active drugs in the treatment of advanced head and neck cancer. The maximum tolerated dose of paclitaxel in combination with carboplatin is currently being evaluated in phase I/II studies. We designed...
Paclitaxel (Taxol; Bristol-Myers Squibb Oncology, Princeton, NJ) and carboplatin have each shown activity against non-small cell lung cancer and they are synergistic in vitro. We thus designed a phase I study to define the maximum tolerated dose and dose-limiting toxicity of the combination with...
510 A phase I study of paclitaxel (taxol®) (TXL) and carboplatin (CBDCA) in the treatment of advanced ovarian cancer510 A phase I study of paclitaxel (taxol®) (TXL) and carboplatin (CBDCA) in the treatment of advanced ovarian cancerCELL-CELL ADHESIONCELL...
Paclitaxel and carboplatin is currently on the clinical utility rates of anti-cancer drug, often used in combination on the clinical treatment of different types of cancer. 翻译结果4复制译文编辑译文朗读译文返回顶部 taxol and platinum are the clinical utility of a very high rate, and the anti-tum...
Paclitaxel (Taxol®) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC We assessed the efficacy and toxicity of low-dose paclitaxel (Taxol庐) given combined with carboplatin before radiotherapy, and with cisplatin concomitantl... Olli-Pekka,Is...
With the introduction of taxanes in the early 1990s, paclitaxel (Taxol) demonstrated single-agent activity of 21% to 24%, with a 40% 1-year survival rate in metastatic disease. The next generation of phase I/II studies evaluated the efficacy of paclitaxel in combination with carboplatin. ...
9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook carboplatin (redirected fromCarboplatinum) Medical [¦kär·bō′plat·ən] (medicine) A platinum coordination compound and anticancer agent used for advanced gynecologic malignancies, especially ovarian tumors, an...